Cargando…

Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China

BACKGROUND: Chronic liver disease has emerged as a leading cause of non-acquired immune deficiency syndrome (AIDS)-related mortality in hepatitis C virus (HCV)/human immunodeficiency virus (HIV)-coinfected patients. The relationship between CD4 cell count and HIV-related opportunistic infections and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Weiyin, Zhong, Huolin, Wen, Chunyan, He, Yaozu, Zheng, Xiaowen, Li, Hong, Chen, Xiejie, He, Haolan, Chen, Jinfeng, Chen, Lijuan, Liu, Cong, Tang, Xiaoping, Cai, Weiping, Li, Linghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943990/ https://www.ncbi.nlm.nih.gov/pubmed/36574222 http://dx.doi.org/10.1097/CM9.0000000000002502

Ejemplares similares

A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China
por: Lin, Weiyin, et al.
Publicado: (2023)

Early on-treatment plasma interleukin-18 as a promising indicator for long-term virological response in patients with HIV-1 infection
por: Lin, Weiyin, et al.
Publicado: (2023)

Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China
por: He, Yaozu, et al.
Publicado: (2023)

Transcriptome analysis of CD4(+) T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity
por: Chen, Jingliang, et al.
Publicado: (2023)

Expression and characterization of a Talaromyces marneffei active phospholipase B expressed in a Pichia pastoris expression system
por: He, Yan, et al.
Publicado: (2016)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013)

Pure Red Cell Aplasia Caused by Parvovirus B19 in Patients with Human Immunodeficiency Virus Infection: A Series of Four Cases
por: Xu, Feilong, et al.
Publicado: (2023)

A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients
por: Shen, Tao, et al.
Publicado: (2011)

Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
por: Heil, Emily L., et al.
Publicado: (2010)

The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023)

Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome
por: Chen, Xiaoman, et al.
Publicado: (2022)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
por: Pinchera, Biagio, et al.
Publicado: (2023)

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
por: Vogel, Martin, et al.
Publicado: (2009)

Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients
por: Liang, Yuanhao, et al.
Publicado: (2021)

The Association of TLR2, TLR3, and TLR9 Gene Polymorphisms With Susceptibility to Talaromycosis Among Han Chinese AIDS Patients in Guangdong
por: Wang, Min, et al.
Publicado: (2021)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

HCV coinfection aggravated the decrease of platelet counts, but not mean platelet volume in chronic HIV-infected patients
por: Lv, Linting, et al.
Publicado: (2018)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2017)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals
por: Naggie, Susanna, et al.
Publicado: (2015)

Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China
por: Deng, Xizi, et al.
Publicado: (2022)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients
por: Emery, Joel, et al.
Publicado: (2010)

Correction: Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China
por: Chen, Song, et al.
Publicado: (2013)

Correction: Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China
por: Chen, Song, et al.
Publicado: (2013)

Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China
por: Chen, Song, et al.
Publicado: (2012)

Therapeutic issues in HIV/HCV-coinfected patients
por: Sulkowski, M S, et al.
Publicado: (2007)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Evidence for Implementation: HIV/HCV Coinfection and Pregnancy
por: Curtis, Megan Rose, et al.
Publicado: (2023)

Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV–HCV-Coinfected Individuals
por: Chen, Xiaochen, et al.
Publicado: (2020)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
por: Wang, Yu, et al.
Publicado: (2021)

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u8p7jmvq6q01gqgbj2llmmkp9r